Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

FDA chief of staff departs: FDA Chief of Staff Susan Winckler has resigned her post at the agency. Appointed to the role in 2006 by former FDA commissioner Andrew von Eschenbach, Winckler coordinated staff activities in the Office of the Commissioner and served as the principal liaison to Health and Human Services officials. With the establishment of the Office of the Chief of Staff in 2007, Winckler enhanced her role as the major point of contact between FDA centers and offices and the commissioner

You may also be interested in...



People In Brief

The latest moves by movers and shakers in the medical device and diagnostics industries.

GE’s ‘Healthymagination’ Campaign Reflects New Focus On Low Cost Products

GE will shift more of its health care R&D spending toward lower-priced medical products over the next six years under an initiative announced May 7

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027607

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel